ArticleScientific reports2021

DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.

Xu Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.